Intellectual Property Transactions
McKenna Long & Aldridge (MLA) IP attorneys understand the many ways intellectual property can further clients’ business strategies. Regularly advising on IP transactions, MLA works hand in hand with clients in successfully developing, acquiring, selling, commercializing, enforcing, and otherwise utilizing intellectual property assets.
Whether your business is an entrepreneurial start-up just forming around a new idea or an established multinational with a worldwide intellectual property portfolio, our interdisciplinary team of business-minded attorneys provides support and advice on the full range of related issues and disputes. We work closely with you in developing legal solutions that align with your specific commercial objectives. Our versatile team possesses extensive intellectual property law experience—imparting both insightful industry knowledge together with sharp business acumen.
Our transaction specific experience includes:
- filing and prosecuting patent, trademark, and copyright applications
- providing strategic counseling
- generating revenue through licensing and otherwise leveraging intellectual property assets
- advising on trade secrets
- managing intellectual property litigation and enforcement costs
Our intellectual property attorneys creatively prosecute clients’ intellectual property and aggressively enforce and defend clients’ rights in cases in the U.S. Patent and Trademark Office and federal and state courts.
Through years of serving a diverse array of clients, our intellectual property attorneys have developed experience in such notable industries as:
- biotech and life sciences
- software and information technology
- clean technologies
- sports and entertainment
- action sports
- consumer products
We also advise clients on cutting-edge issues arising in new media, including the continually evolving internet and growing social media. Our extensive knowledge in these areas has enabled us to react quickly with proven strategic advice.
Our practice regularly conducts due diligence in advance of transactions to sell, purchase, or license intellectual property, representing buyers, sellers, licensors, licensees, and secured parties. Working with MLA’s Corporate Department, we also regularly review intellectual property representation and warranty provisions, indemnity clauses, and non-compete clauses in merger, acquisition, and other corporate documents.
Moreover, our practice works closely with MLA’s Global Patent Litigation group—coordinating international and domestic enforcement programs. Utilizing a distinct, multi-tiered strategy to maximize IP assets, we blend the most effective mix of options for each matter, involving licensing, joint ventures, pooling arrangements and other vehicles to monetize IP.
Our distinguished attorneys frequently lecture, publish articles, and conduct presentations on current issues facing the IP licensing community, including developments in the law of patent exhaustion, managing intellectual property licensing programs abroad, and the interplay of antitrust and intellectual property law. MLA’s IP transactional practice also recently authored an amicus brief to the U.S. Supreme Court in the matter of LG Electronics, Inc. v. Quanta Computer, Inc.
With experience ranging from domestic to international agreements, and projects covering multiple types of rights, MLA’s intellectual property practice understands the role of intellectual property in business today.
- Microsoft, Inc. v. Motorola, Inc., et al. (April 25, 2013): Standard Essential Patents and Guidance regarding “RAND” License CommitmentsMay 2, 2013
- May 16, 2012
- March 30, 2012Following its decision in Bilski, on March 20, 2012, a unanimous (9-0) Supreme Court handed down its decision in Mayo v. Prometheus-the Court’s second opinion on patentable subject matter in less than two years. Prometheus is the sole and exclusive licensee of U.S. Patent Nos. 6,355,623 and 6,680,302, which claim methods for determining the optimal dosage of thiopurine drugs used to treat immune-mediated gastrointestinal disorders, and marketed a PROMETHEUS Thiopurine Metabolites test that used the technology covered by the patents-in-suit.
- Seidman joins McKenna Long & Aldridge
- McKenna Long Hires Rival’s Entire IP Team
- Behind China's surge in patents